1. Home
  2. SABS vs GP Comparison

SABS vs GP Comparison

Compare SABS & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • GP
  • Stock Information
  • Founded
  • SABS 2014
  • GP 2010
  • Country
  • SABS United States
  • GP Canada
  • Employees
  • SABS N/A
  • GP N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • GP Construction/Ag Equipment/Trucks
  • Sector
  • SABS Health Care
  • GP Consumer Discretionary
  • Exchange
  • SABS Nasdaq
  • GP Nasdaq
  • Market Cap
  • SABS 11.4M
  • GP 12.7M
  • IPO Year
  • SABS N/A
  • GP 2020
  • Fundamental
  • Price
  • SABS $1.75
  • GP $0.44
  • Analyst Decision
  • SABS Strong Buy
  • GP Strong Buy
  • Analyst Count
  • SABS 5
  • GP 2
  • Target Price
  • SABS $11.40
  • GP $2.33
  • AVG Volume (30 Days)
  • SABS 25.4K
  • GP 61.6K
  • Earning Date
  • SABS 05-19-2025
  • GP 02-14-2025
  • Dividend Yield
  • SABS N/A
  • GP N/A
  • EPS Growth
  • SABS N/A
  • GP N/A
  • EPS
  • SABS N/A
  • GP N/A
  • Revenue
  • SABS $1,322,410.00
  • GP $20,656,035.00
  • Revenue This Year
  • SABS N/A
  • GP N/A
  • Revenue Next Year
  • SABS $50.00
  • GP $94.25
  • P/E Ratio
  • SABS N/A
  • GP N/A
  • Revenue Growth
  • SABS N/A
  • GP N/A
  • 52 Week Low
  • SABS $1.00
  • GP $0.41
  • 52 Week High
  • SABS $5.01
  • GP $1.91
  • Technical
  • Relative Strength Index (RSI)
  • SABS 63.35
  • GP 40.90
  • Support Level
  • SABS $1.30
  • GP $0.42
  • Resistance Level
  • SABS $1.49
  • GP $0.46
  • Average True Range (ATR)
  • SABS 0.14
  • GP 0.03
  • MACD
  • SABS 0.06
  • GP 0.01
  • Stochastic Oscillator
  • SABS 100.00
  • GP 31.11

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

Share on Social Networks: